, adult patients with MMD or MMS who presented with transient ischemic attack (TIA) or cerebral infarction within 2 weeks with significant perfusion deficits lacking sufficient collaterals were Background and Purpose-In patients with acute symptomatic moyamoya (<2 weeks), the feasibility of a combination therapy of multiple burr hole procedure under local anesthesia and intravenous erythropoietin pretreatment was assessed. We also identified the factors associated with transdural revascularization. Methods-In this prospective single-arm study, perfusion-impaired patients presenting with transient ischemic attack or acute cerebral infarction were assessed. Combination therapy was performed to patients lacking transdural collaterals. Primary outcomes were evaluated clinically with modified Rankin Scale scores and radiologically with revascularization success (transhemispheric, trans-burr hole, and sufficient revascularizations [filling ≥33% of ipsilateral supratentorium]) at 6 months. Treatment-related adverse events were analyzed in 3 phases: pre burr hole, post burr hole, and after-discharge as secondary outcome. Factors associated with sufficient revascularization were investigated. Results-Fifty hemispheres from 37 patients were included. Compared with discharge, modified Rankin Scale score at 6 months significantly improved ( There was no significant pre burr hole or post burr hole complication. Two (5.4%) transient ischemic attack and 1 (2.7%) cerebral infarction occurred after discharge. Presentation with acute infarction (odds ratio, 4.8; 95% confidence interval, 1.1-21.4), ipsilateral basal moyamoya vessels (odds ratio, 13.9; 95% confidence interval, 1.3-144.2), and delayed mean transit time (odds ratio, 3.9; 95% confidence interval, 1.3-12.2) predicted sufficient revascularization. 
R evascularization surgery for moyamoya disease (MMD) or moyamoya syndrome (MMS) focuses on formation of transdural collaterals from the external carotid artery, the most protective vascular channel against impending ischemia. 1 However, in neurologically unstable presentations, surgery under general anesthesia can be risky because of complications. 2 Alternatively, multiple burr hole procedure, an indirect bypass strategy, has been used restrictively as a sole revascularization modality. 3 Although it carries a low risk of perioperative complications, 4 it cannot guarantee stable arteriogenesis through the transdural detours, especially in adult MMD. 3 EPO (erythropoietin), an erythroid growth factor, is also known for its angiogenic potential on endothelial cells. 5 Proven safe even in high-dose administration for human translational trials, 6 it is an attractive candidate drug to promote revascularization. In moyamoya patients with acute ischemic presentation, we evaluated the feasibility of a combination therapy using multiple burr hole procedure to avoid perfusion aggravation, while promoting arteriogenesis by intravenous EPO pretreatment. We further identified the factors associated with revascularization.
Methods
Supporting data for this study are available from the corresponding author on reasonable request. enrolled. Detailed inclusion criteria, exclusion criteria, and methods are included in the online-only Data Supplement. After enrollment, the patients were managed according to acute stroke care including stroke unit care and flow augmentation therapy as needed.
For the combination therapy, intravenous EPO (Epokine; CJ healthcare, South Korea) was used preprocedure to promote revascularization. Total 120 000 U of EPO was injected for 3 consecutive days. 7 The multiple burr hole procedure was performed under local anesthesia and conscious sedation in an area of hemodynamic insufficiency. The patients were usually discharged after a 7-day observation period. Revascularization status was accessed by 6-month transfemoral cerebral angiography. Transfemoral cerebral angiography was performed and clinically reviewed by a neuroradiologist. The study was conducted under approval of the institutional review board. All patients gave written informed consent.
Patient Analysis
Procedure-related adverse events were analyzed overall, and according to presentation subtypes (cerebral infarction or TIA) by temporal relation to combination therapy: pre burr hole period, post burr hole period (after procedure, while admitted), and after-discharge period (up to 6 months). Functional outcomes and adverse events were analyzed by National Institutes of Health Stroke Scale (NIHSS) score and modified Rankin Scale score.
Hemispheric Analysis
Revascularization was analyzed on a hemispheric basis. Revascularization success was evaluated in the 6-month angiography lateral images. Local revascularization was assessed by transhemispheric (any arteriogenesis and vascular filling via burr holes per hemisphere) and trans-burr hole (any arteriogenesis and vascular filling via each burr holes) arteriogenesis. Hemispheric revascularization was assessed by relative revascularization area (RA). The relative RA was calculated as RA/supratentorial area. 8 Then, it was graded as excellent (≥66%), good (≥33%), fair (<33%), and poor (none). 9 Computed tomographic perfusion values were analyzed.
Determinants of Sufficient Revascularization
For analysis of hemispheric profiles, sufficient revascularization was classified as relative RA ≥33%. For analysis of patient profiles, sufficient revascularization was classified as relative RA ≥33% in unilateral population and relative RA ≥33% in any of the 2 hemispheres in the bilateral population. Comparison of clinical and hemispheric profiles was performed according to 6-month sufficient revascularization. Multiple logistic regression analysis was performed including potentially significant variables (P<0.2; IBM SPSS Statistics 22; IBM, Chicago, IL).
Results

General Demographics
During the study period, 113 patients were monitored. A total of 37 patients were eligible for the final analysis ( Figure I in the online-only Data Supplement). Of the 37 patients, 26 (70.3%) presented with cerebral infarct, and 11 (29.7%) presented with TIA. MMD was 16 (43.2%) and MMS 21 (56.8%; Table 1 ). Of 50 operated hemispheres, diffusion-weighted image lesions were positive in 28 (56.0%), and basal moyamoya was documented in 25 (50.0%).
Adverse Events
In the pre burr hole period, 9 (24.3%) patients experienced progression and 4 (10.8%) fluctuation. In the post burr hole period, 3 (8.1%) patients experienced lesion extension (asymptomatic), and 4 (10.8%) patients experienced fluctuation (none resulted in worsening of final neurological outcome; Table 1 ). All neurological progression and fluctuation subsided before discharge. EPO did not cause symptomatic erythrocytosis or thrombocytosis. No new-onset or malignant hypertension occurred. For thromboembolic complications, 1 patient showed regional wall motion abnormality in echocardiography at admission, unrelated to EPO use. After stabilization of patient, coronary intervention was performed.
In the after-discharge period, 5 experienced behavioral change, 4 seizure, 2 TIAs, and 1 symptomatic ischemic stroke. TIAs gradually subsided. The patient who experienced ischemic stroke had a modified Rankin Scale score of 1 at 6 months. Adverse events experienced in post burr hole period and after-discharge period are described in Table I 
Clinical and Radiological Outcomes
Overall, patients presented with a median NIHSS score of 2 (range, 0-22) were discharged with a median NIHSS score of 1 (0-15) and showed a 6-month NIHSS score of 0 (0-12). The median modified Rankin Scale score at discharge was 2 (0-5), whereas 6-month modified Rankin Scale score was 1 (0-4), with significant improvement (P<0.001; Table 2 ).
Transhemispheric arteriogenesis was seen in 49 out of 50 hemispheres (98.0%). Trans-burr hole arteriogenesis was seen in 128 out of 143 burr holes (89.5%). In terms of relative RA, 8 achieved excellent collaterals, 17 good, 23 fair, and only 1 none (P<0.001). Twenty-six out of 50 (52.0%) hemispheres fulfilled criteria for sufficient revascularization. Compared with baseline perfusion parameters, cerebral blood flow (P<0.001), time to peak (P=0.002), and mean transit time (MTT) (P<0.001) significantly improved ( Table 2) . Examples of the 4 grades of reperfusion by relative RA on angiography and corresponding computed tomographic perfusion improvements are shown in the Figure. 
Profiles Associated With Sufficient Revascularization
In the patient analysis (23 sufficient and 14 insufficient), female sex, diabetes mellitus, cerebral infarction, and MMD compared with MMS were included in the multivariate analysis. Presentation with cerebral infarct was associated with sufficient revascularization (odds ratio, 4.75; 95% confidence interval, 1.06-21.36; P=0.042).
In the hemispheric analysis (26 sufficient and 24 insufficient hemispheres), ipsilateral diffusion-weighted image lesions, unilateral moyamoya, ipsilateral basal moyamoya, cerebral blood flow, and MTT values (while both MTT and time to peak were significant in univariate analysis, only MTT was included to avoid multicollinearity) were included into the multivariate analysis. Presence of ipsilateral basal moyamoya (odds ratio, 13 After-discharge period 
Discussion
In this series of 37 adult patients with MMD treated with combination therapy, patients did not experience further major ischemic events up to 6 months after procedure. Postprocedure outcomes were overall acceptable considering the acute neurological presentation of the patients. In patients with MMD, high rates of postoperative stroke and complications after revascularization (up to 21%, even mortality in 9%) are reported. 10 Preoperative cerebral infarction or acute clinical course increases such risk, and surgery is generally recommended to be delayed beyond the acute period. 11 However, not all clinical situations permit such delay, and emergent collateral formation may be needed. We were able to address this need by reducing ischemic complications to a tolerable degree using local anesthesia and minimally invasive procedure instead of general anesthesia. Furthermore, no hyperperfusion syndrome was observed, supporting the safety of this method.
In analysis of factors that are associated with revascularization, cerebral infarction, ipsilateral basal moyamoya vessels, and prolonged MTT values were significant. It can be evidenced that hemodynamic compromise is a driving force for revascularization. Presentation with cerebral infarction reflects acute hypoxia. Basal moyamoya vessels 12 and delay in cerebral circulation time parameters may represent severe hemodynamic compromise.
Our results did not show the significance of conventional factors such as age, MMD or MMS, or smoking on revascularization. We cannot be sure if this is the effect of EPO pretreatment or represents situations of physiological vasculogenesis in dural arteriovenous fistulas or diabetic ophthalmic neovascularization, which tends to increase with age. 13 The current study has some limitations. A major limitation is that the patients in our study were not randomized. Thus, the respective roles of intravenous EPO and burr hole procedure on positive outcomes are not clear. To address this issue, our institution is currently undergoing a prospective study that randomizes patients with MMD to intravenous EPO pretreatment versus no pretreatment before multiple burr hole procedure (clinicaltrials.gov: NCT02603406). Another limitation is the underestimation of RA. For this study, we modified the postoperative arteriographic reperfusion staging criteria 9 through measuring relative RA using lateral projections. 8 The actual perfusion deficits in patients with MMD vary, and usually does not involve the posterior cerebral artery territory, although this method includes such territories, underestimating the outcomes. A third limitation is that we are not able to clarify the exact timing of arteriogenesis. Although such verification is important to optimize the indications for the combination therapy, the invasive nature of transfemoral cerebral angiography is a limitation. Development of noninvasive modalities that can document revascularization is needed in future studies.
In conclusion, our data suggest that combination therapy of multiple burr hole therapy with intravenous EPO is a safe 
